Ross MI - Search Results

1

Malignant melanoma: relationship of the human leukocyte antigen class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II.

Lee JE, Lu M, Mansfield PF, Platsoucas CD, Reveille JD, Ross MI. Lee JE, et al. Among authors: ross mi. Cancer. 1996 Aug 15;78(4):758-63. doi: 10.1002/(SICI)1097-0142(19960815)78:4<758::AID-CNCR11>3.0.CO;2-U. Cancer. 1996. PMID: 8756369

2

Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanoma.

Itoh K, Salmeron MA, Morita T, Seito D, Mansfield PF, Ross MI, Balch CM, Augustus LB. Itoh K, et al. Among authors: ross mi. Int J Cancer. 1992 Aug 19;52(1):52-9. doi: 10.1002/ijc.2910520112. Int J Cancer. 1992. PMID: 1500228

3

The current management of cutaneous melanoma.

Ross MI, Balch CM. Ross MI, et al. Adv Surg. 1991;24:139-200. Adv Surg. 1991. PMID: 1996522 Review.

4

Patterns of failure in anorectal melanoma. A guide to surgical therapy.

Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C. Ross M, et al. Arch Surg. 1990 Mar;125(3):313-6. doi: 10.1001/archsurg.1990.01410150035007. Arch Surg. 1990. PMID: 2306178

5

Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control.

Strom EA, Ross MI. Strom EA, et al. Among authors: ross mi. Ann Surg Oncol. 1995 Sep;2(5):445-9. doi: 10.1007/BF02306379. Ann Surg Oncol. 1995. PMID: 7496841

6

Role of computed tomography in the staging of patients with local-regional metastases of melanoma.

Buzaid AC, Tinoco L, Ross MI, Legha SS, Benjamin RS. Buzaid AC, et al. Among authors: ross mi. J Clin Oncol. 1995 Aug;13(8):2104-8. doi: 10.1200/JCO.1995.13.8.2104. J Clin Oncol. 1995. PMID: 7636554

7

Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.

Buzaid AC, Tinoco LA, Jendiroba D, Tu ZN, Lee JJ, Legha SS, Ross MI, Balch CM, Benjamin RS. Buzaid AC, et al. Among authors: ross mi. J Clin Oncol. 1995 Sep;13(9):2361-8. doi: 10.1200/JCO.1995.13.9.2361. J Clin Oncol. 1995. PMID: 7666095

8

Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid).

Fujimaki W, Itoh K, An T, Gano JB, Ross MI, Mansfield PF, Balch CM, Augustus LB, Karkevitch DD, Johnston D, et al. Fujimaki W, et al. Among authors: ross mi. Cancer Biother. 1993 Winter;8(4):307-18. doi: 10.1089/cbr.1993.8.307. Cancer Biother. 1993. PMID: 7804372 Clinical Trial.

9

Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma.

Buzaid A, Legha SS, Balch CM, Ross M, Ring S, Plager C, Papadopoulos NE, el-Naggar AK, Benjamin RS. Buzaid A, et al. Cancer. 1994 Nov 1;74(9):2476-82. doi: 10.1002/1097-0142(19941101)74:9<2476::aid-cncr2820740914>3.0.co;2-z. Cancer. 1994. PMID: 7923003

10

HLA-DQB1*0301 association with increased cutaneous melanoma risk.

Lee JE, Reveille JD, Ross MI, Platsoucas CD. Lee JE, et al. Among authors: ross mi. Int J Cancer. 1994 Nov 15;59(4):510-3. doi: 10.1002/ijc.2910590413. Int J Cancer. 1994. PMID: 7960221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters